SEARCH

SEARCH BY CITATION

References

  • Ajuebor MN, Singh A, Wallace JL (2000). Cyclooxygenase-2-derived prostaglandin D2 is an early anti-inflammatory signal in experimental colitis. Am J Physiol Gastrointest Liver Physiol 279: G238G244.
  • Al Sinawi LA, Mekki QA, Hassan S, Hedges A, Burke C, Moody SG et al. (1985). Effect of a hydantoin prostaglandin analogue, BW245C, during oral dosing in man. Prostaglandins 29: 99111.
  • Almishri W, Cossette C, Rokach J, Martin JG, Hamid Q, Powell WS (2005). Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats. J Pharmacol Exp Ther 313: 6469.
  • Alving K, Matran R, Lundberg JM (1991). Effect of nedocromil sodium on allergen-, PAF-, histamine- and bradykinin-induced airways vasodilatation and pulmonary obstruction in the pig. Br J Pharmacol 104: 452458.
  • Angeli V, Staumont D, Charbonnier AS, Hammad H, Gosset P, Pichavant M et al. (2004). Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J Immunol 172: 38223829.
  • Arimura A, Yasui K, Kishino J, Asanuma F, Hasegawa H, Kakudo S et al. (2001). Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S-5751. J Pharmacol Exp Ther 298: 411419.
  • Armer RE, Ashton MR, Boyd EA, Brennan CJ, Brookfield FA, Gazi L et al. (2005). Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2. J Med Chem 48: 61746177.
  • Barnes PJ (2004). New drugs for asthma. Nat Rev Drug Discov 3: 831844.
  • Bochenek G, Nagraba K, Nizankowska E, Szczeklik A (2003). A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol 111: 743749.
  • Bohm E, Sturm GJ, Weiglhofer I, Sandig H, Shichijo M, McNamee A et al. (2004). 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J Biol Chem 279: 76637670.
  • Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S et al. (2001). Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial. J Allergy Clin Immunol 107: 461468.
  • Caron G, Delneste Y, Roelandts E, Duez C, Bonnefoy JY, Pestel J et al. (2001). Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 167: 36823686.
  • Charlesworth EN, Kagey-Sobotka A, Schleimer RP, Norman PS, Lichtenstein LM (1991). Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 146: 671676.
  • Cheng K, Wu TJ, Wu KK, Sturino C, Metters K, Gottesdiener K et al. (2006). Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci USA 103: 66826687.
  • Cossette C, Walsh SE, Kim S, Lee GJ, Lawson JA, Bellone S et al. (2007). Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils. J Pharmacol Exp Ther 320: 173179.
  • Dahlen SE, Kumlin M (2004). Monitoring mast cell activation by prostaglandin D2in vivo. Thorax 59: 453455.
  • Doyle WJ, Boehm S, Skoner DP (1990). Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 86: 924935.
  • Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J et al. (1997). The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 155: 18281834.
  • Faith A, McDonald J, Peek E, Richards D, Caulfield J, Chevretton E et al. (2005). Functional plasticity of human respiratory tract dendritic cells: GM-CSF enhances T(H)2 development. J Allergy Clin Immunol 116: 11361143.
  • Faveeuw C, Gosset P, Bureau F, Angeli V, Hirai H, Maruyama T et al. (2003). Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. Eur J Immunol 33: 889898.
  • Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, Urade Y (2002). Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 168: 443449.
  • Gazi L, Gyles S, Rose J, Lees S, Allan C, Xue L et al. (2005). Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. Prostaglandins Other Lipid Mediat 75: 153167.
  • Gervais FG, Cruz RP, Chateauneuf A, Gale S, Sawyer N, Nantel F et al. (2001). Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 108: 982988.
  • Gervais FG, Morello JP, Beaulieu C, Sawyer N, Denis D, Greig G et al. (2005). Identification of a potent and selective synthetic agonist at the CRTH2 receptor. Mol Pharmacol 67: 18341839.
  • Giles H, Leff P, Bolofo ML, Kelly MG, Robertson AD (1989). The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br J Pharmacol 96: 291300.
  • Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA (1999). Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698701.
  • Gonzalo J, Qiu Y, Coyle AJ, Hodge MR (2005). CRTH2(DP2) and not DP1 receptor mediate allergen induced mucus production and airway hyperresponsiveness. Am J Respir Crit Care Med 163: A811.
  • Gosset P, Pichavant M, Faveeuw C, Bureau F, Tonnel AB, Trottein F (2005). Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response. Eur J Immunol 35: 14911500.
  • Gyles SL, Xue L, Townsend ER, Wettey F, Pettipher R (2006). A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants. Immunology 119: 362368.
  • Hahn EL, Bacharier LB (2005). The atopic march: the pattern of allergic disease development in childhood. Immunol Allergy Clin North Am 25: 231246.
  • Hamid-Bloomfield S, Whittle BJ (1989). Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C. Br J Pharmacol 96: 307312.
  • Hammad H, de Heer HJ, Soullie T, Hoogsteden HC, Trottein F, Lambrecht BN (2003). Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J Immunol 171: 39363940.
  • Hammad H, Kool M, Soullie T, Narumiya S, Trottein F, Hoogsteden HC et al. (2007). Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 204: 357367.
  • Heavey DJ, Lumley P, Barrow SE, Murphy MB, Humphrey PP, Dollery CT (1984). Effects of intravenous infusions of prostaglandin D2 in man. Prostaglandins 28: 755767.
  • Heinemann A, Schuligoi R, Sabroe I, Hartnell A, Peskar BA (2003). Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis. J Immunol 170: 47524758.
  • Hirai H, Tanaka K, Takano S, Ichimasa M, Nakamura M, Nagata K (2002). Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. J Immunol 168: 981985.
  • Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y et al. (2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193: 255261.
  • Howarth P, Walsh S, Robinson C (1991). The comparative nasal effects of prostaglandin D2 in normal and rhinitic subjects. Adv Prostaglandin Thromboxane Leukot Res 21A: 449452.
  • Howarth PH (1997). Mediators of nasal blockage in allergic rhinitis. Allergy 52: 1218.
  • Kitawaki T, Kadowaki N, Sugimoto N, Kambe N, Hori T, Miyachi Y et al. (2006). IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. Int Immunol 18: 17891799.
  • Kostenis E, Ulven T (2006). Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol Med 12: 148158.
  • Lambrecht BN (2005). Dendritic cells and the regulation of the allergic immune response. Allergy 60: 271282.
  • Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, Roberts LJ (1982). Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 129: 16271631.
  • Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidarov I, Behan DP, Connolly DT (2006). Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol 126: 26372646.
  • Maezawa Y, Nakajima H, Kumano K, Kubo S, Karasuyama H, Iwamoto I (2003). Role of IgE in Th2 cell-mediated allergic airway inflammation. Int Arch Allergy Immunol 131 (Suppl 1): 26.
  • Maezawa Y, Nakajima H, Seto Y, Suto A, Kumano K, Kubo S et al. (2004). IgE-dependent enhancement of Th2 cell-mediated allergic inflammation in the airways. Clin Exp Immunol 135: 1218.
  • Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K et al. (2000). Prostaglandin D2 as a mediator of allergic asthma. Science 287: 20132017.
  • Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM (2001). Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 108: 18651873.
  • McKenniff MG, Norman P, Cuthbert NJ, Gardiner PJ (1991). BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro. Br J Pharmacol 104: 585590.
  • Mimura H, Ikemura T, Kotera O, Sawada M, Tashiro S, Fuse E et al. (2005). Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2. J Pharmacol Exp Ther 314: 244251.
  • Monneret G, Gravel S, Diamond M, Rokach J, Powell WS (2001). Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98: 19421948.
  • Monneret G, Li H, Vasilescu J, Rokach J, Powell WS (2002). 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol 168: 35633569.
  • Murray JJ, Tonnel AB, Brash AR, Roberts LJ, Gosset P, Workman R et al. (1986). Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 315: 800804.
  • Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson Jr NF, Meyers DA, Norman PS et al. (1983). Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 128: 597602.
  • Nagai H, Takeda H, Yamaguchi S, Tanaka H, Matsuo A, Inagaki N (1995). The effect of a thromboxane A2 receptor antagonist BAY-u-3405 on experimental allergic reactions. Prostaglandins 50: 7587.
  • Nagata K, Hirai H, Tanaka K, Ogawa K, Aso T, Sugamura K et al. (1999a). CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 459: 195199.
  • Nagata K, Tanaka K, Ogawa K, Kemmotsu K, Imai T, Yoshie O et al. (1999b). Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 162: 12781286.
  • Narita S, Asakura K, Kataura A (1996). Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int Arch Allergy Immunol 109: 161166.
  • O'Sullivan S, Dahlen B, Dahlen SE, Kumlin M (1996). Increased urinary excretion of the prostaglandin D2 metabolite 9 α, 11 β-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 98: 421432.
  • Peters SP, Schleimer RP, Kagey-Sobotka A, Naclerio RM, MacGlashan Jr DW, Schulman ES et al. (1982). The role of prostaglandin D2 in IgE-mediated reactions in man. Trans Assoc Am Physicians 95: 221228.
  • Pettipher R, Hansel TT, Armer R (2007). Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov 6: 313325.
  • Reddy ST, Tiano HF, Langenbach R, Morham SG, Herschman HR (1999). Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells. Biochem Biophys Res Commun 265: 205210.
  • Sandig H, Andrew D, Barnes AA, Sabroe I, Pease J (2006). 9α,11β-PGF2 and its stereoisomer PGF2α are novel agonists of the chemoattractant receptor, CRTH2. FEBS Lett 580: 373379.
  • Sandig H, Pease JE, Sabroe I (2007). Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. J Leukoc Biol 81: 372382.
  • Satoh T, Moroi R, Aritake K, Urade Y, Kanai Y, Sumi K et al. (2006). Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 177: 26212629.
  • Sawyer N, Cauchon E, Chateauneuf A, Cruz RP, Nicholson DW, Metters KM et al. (2002). Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 137: 11631172.
  • Schuligoi R, Schmidt R, Geisslinger G, Kollroser M, Peskar BA, Heinemann A (2007). PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors. Biochem Pharmacol 74: 107117.
  • Shiraishi Y, Asano K, Nakajima T, Oguma T, Suzuki Y, Shiomi T et al. (2005). Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther 312: 954960.
  • Sihra BS, Kon OM, Durham SR, Walker S, Barnes NC, Kay AB (1997). Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax 52: 447452.
  • Sousa A, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz-Schumann M et al. (1997). Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 52: 940945.
  • Spik I, Brenuchon C, Angeli V, Staumont D, Fleury S, Capron M et al. (2005). Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J Immunol 174: 37033708.
  • Stubbs VE, Schratl P, Hartnell A, Williams TJ, Peskar BA, Heinemann A et al. (2002). Indomethacin causes prostaglandin D2-like and eotaxin-like selective responses in eosinophils and basophils. J Biol Chem 277: 2601226020.
  • Sturino CF, O'Neill G, Lachance N, Boyd M, Berthelette C, Labelle M et al. (2007). Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocy clopenta[b]indol-3-yl]-acetic acid (MK-0524). J Med Chem 50: 794806.
  • Sugimoto H, Shichijo M, Iino T, Manabe Y, Watanabe A, Shimazaki M et al. (2003). An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther 305: 347352.
  • Takeshita K, Yamasaki T, Nagao K, Sugimoto H, Shichijo M, Gantner F et al. (2004). CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int Immunol 16: 947959.
  • Tanaka K, Hirai H, Takano S, Nakamura M, Nagata K (2004). Effects of prostaglandin D2 on helper T cell functions. Biochem Biophys Res Commun 316: 10091014.
  • Tanaka K, Ogawa K, Sugamura K, Nakamura M, Takano S, Nagata K (2000). Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. J Immunol 164: 22772280.
  • Terada N, Yamakoshi T, Hasegawa M, Tanikawa H, Maesako K, Ishikawa K et al. (1998). The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis. Acta Otolaryngol Suppl 537: 3237.
  • Theiner G, Gessner A, Lutz MB (2006). The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo. Immunobiology 211: 463472.
  • Trivedi SG, Newson J, Rajakariar R, Jacques TS, Hannon R, Kanaoka Y et al. (2006). Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc Natl Acad Sci USA 103: 51795184.
  • Uller L, Mathiesen JM, Alenmyr L, Korsgren M, Ulven T, Hogberg T et al. (2007). Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Respir Res 8: 16.
  • Ulven T, Kostenis E (2005). Minor structural modifications convert the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist. J Med Chem 48: 897900.
  • van Neerven RJ, Knol EF, Ejrnaes A, Wurtzen PA (2006). IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy. Int Arch Allergy Immunol 141: 119129.
  • van Rijt LS, Jung S, Kleinjan A, Vos N, Willart M, Duez C et al. (2005). In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 201: 981991.
  • Vinall SL, Townsend ER, Pettipher R (2007). A paracrine role for chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2(+) CD4(+) T helper type 2 lymphocytes. Immunology 121: 577584.
  • Walch L, Labat C, Gascard JP, de MV, Brink C, Norel X (1999). Prostanoid receptors involved in the relaxation of human pulmonary vessels. Br J Pharmacol 126: 859866.
  • Wang YH, Ito T, Wang YH, Homey B, Watanabe N, Martin R et al. (2006). Maintenance and polarization of human Th2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity 24: 827838.
  • Whittle BJ, Moncada S, Mullane K, Vane JR (1983). Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue. Prostaglandins 25: 205223.
  • Widdicombe JG (1990). Nasal pathophysiology. Respir Med 84 (Suppl A): 39.
  • Wright DH, Ford-Hutchinson AW, Chadee K, Metters KM (2000). The human prostanoid DP receptor stimulates mucin secretion in LS174 T cells. Br J Pharmacol 131: 15371545.
  • Xue L, Gyles SL, Barrow A, Pettipher R (2007). Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D2. Biochem Pharmacol 73: 843853.
  • Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG et al. (2005). Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 175: 65316536.
  • Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D et al. (2005). Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 174: 81838190.